Commentary: When cancer is oligometastatic, even mesothelioma is curable

Our plain-English summary of Commentary: When cancer is oligometastatic, even mesothelioma is curable, by A.E. Abbas (JTCVS Techniques, 2020).

The study

• Author: A.E. Abbas
• Journal: JTCVS Techniques
• Published: 2020;3:361-362
• Type of article: Editorial
• Read it: PubMed · Publisher · Free full text

In plain English

This article was a short commentary, not an original study, and it reported no new patient data. It responded to a case report by Li and colleagues about a patient with epithelioid malignant pleural mesothelioma. That patient remained disease-free 3.5 years after surgery to remove a single brain metastasis, which had appeared more than 2 years after radical pleurectomy. The author noted that such cases are rare and pointed to a similar 1995 report by Kitai and colleagues. Citing other published work, the author said that mesothelioma usually causes death through local spread, but that autopsy studies show most patients have spread through the bloodstream by the time of death. The author argued that attention should go to "oligometastatic" disease rather than to the type of primary cancer. This term means a small number of metastases that can all be removed or destroyed by surgery or ablation. The author concluded that such metastases should be carefully considered for this treatment whenever complete eradication is deemed possible. The commentary did not discuss asbestos exposure.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: Commentary (opinion piece) on a published case report; no original data
• Who was studied: No population studied. The commentary discussed one patient described in a separate case report by Li and colleagues: a patient with epithelioid malignant pleural mesothelioma (MPM) and a single brain metastasis.
• Main results:
  • Not a finding of this article. The commentary described the Li and colleagues case: the brain metastasis appeared more than 2 years after radical pleurectomy, and the patient was disease-free 3.5 years after it was removed.
  • Not a finding of this article. The commentary cited a 1995 report by Kitai and colleagues of a similar patient with epithelioid MPM who had no recurrence 3 years after removal of a single brain metastasis.
  • Not a finding of this article. The commentary cited autopsy studies showing that most patients with MPM have spread through the bloodstream at the time of death.
• The authors' conclusion: The author concluded that oligometastases should always be carefully considered for local treatment (surgery or ablation) when complete eradication is deemed possible, regardless of the type of primary cancer.

Topics

Medical terms in this study, explained in our Lexicon: Mesothelioma.

Related studies

• Commentary: A return trip to MARS: Less may be more when treating mesothelioma — C.M. Griffin, V.H. van Berkel (2022)
• Australia's Ongoing Legacy of Asbestos: Significant Challenges Remain Even after the Complete Banning of Asbestos Almost Fifteen Years Ago — M. Soeberg, D.A. Vallance, et al. (2018)
• Mesothelioma continues to increase even 40 years after exposure - Evidence from long-term epidemiological observation — B. Świątkowska, N. Szeszenia-Dąbrowska (2017)
• Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards — S.M. Christ, P. Heesen, et al. (2023)
• Successful treatment of a patient with oligometastatic mesothelioma to the brain — S.S. Li, D.A. Steimer, et al. (2020)
• Mesothelioma: has patient had contact with even small amount of asbestos? — K. Garrahan (1987)

Browse return to medical research.